Calcium remodeling in colorectal cancer

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1864, Issue 6, 2017, Pages 843-849

  Villalobos, Carlos ^a   Sobradillo, Diego ^a   Hernández Morales, Miriam ^a   Núñez, Lucía ^a  

^a University of Valladolid   (Spain)

Author keywords

Aspirin; Colorectal cancer; Non steroidal anti inflammatory drugs; Orai1; STIM1; STIM2; Store operated Ca2 + entry; TRPC1

Indexed keywords

CALCIUM; NONSTEROID ANTIINFLAMMATORY AGENT; SALICYLIC ACID; STROMAL INTERACTION MOLECULE 1; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY C, MEMBER 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL C;

CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; COLORECTAL CANCER; DRUG EFFICACY; EVIDENCE BASED PRACTICE; HUMAN; META ANALYSIS (TOPIC); MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SECOND MESSENGER; STORE OPERATED CALCIUM ENTRY; COLORECTAL TUMOR; HOMEOSTASIS; METABOLISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALCIUM; COLORECTAL NEOPLASMS; HOMEOSTASIS; HUMANS; STROMAL INTERACTION MOLECULE 1; TRPC CATION CHANNELS;

EID: 85009782220     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2017.01.005     Document Type: Review

References (66)

1. [1] Marley, A.R., Nan, H., Epidemiology of colorectal cancer. Int. J. Mol. Epidemiol. Genet. 7 (2016), 105–114.
2. [2] Coyle, C., Cafferty, F.H., Langley, R.E., Aspirin and colorectal cancer prevention and treatment: is it for everyone?. Curr. Colorectal Cancer Rep. 12 (2016), 27–34.
3. [3] Baron, J.A., Cole, B.F., Sandler, R.S., Haile, R.W., Ahnen, D., Bresalier, R., McKeown-Eyssen, G., Summers, R.W., Rothstein, R., Burke, C.A., Snover, D.C., Church, T.R., Allen, J.I., Beach, M., Beck, G.J., Bond, J.H., Byers, T., Greenberg, E.R., Mandel, J.S., Marcon, N., Mott, L.A., Pearson, L., Saibil, F., van Stolk, R.U., A randomized trial of aspirin to prevent colorectal adenomas. N. Engl. J. Med. 348 (2003), 891–899.
4. [4] Sandler, R.S., Halabi, S., Baron, J.A., Budinger, S., Paskett, E., Keresztes, R., Petrelli, N., Pipas, J.M., Karp, D.D., Loprinzi, C.L., Steinbach, G., Schilsky, R.A., A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N. Engl. J. Med. 348 (2003), 883–890.
5. [5] Xu, X.M., Sansores-Garcia, L., Chen, X.M., Matijevic-Aleksic, N., Du, M., Wu, K.K., Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 5292–5297.
6. [6] Hanif, R., Pittas, A., Feng, Y., Koutsos, M.I., Qiao, L., Staiano-Coico, L., Shiff, S.I., Rigas, B., Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52 (1996), 237–245.
7. [7] Smith, W.L., DeWitt, D.L., Garavito, R.M., Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000), 145–182.
8. [8] Molina, M.A., Sitja-Arnau, M., Lemoine, M.G., Frazier, M.L., Sinicrope, F.A., Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res. 59 (1999), 4356–4362.
9. [9] Perugini, R.A., McDade, T.P., Vittimberga, F.J., Duffy, A.J., Callery, M.P., Sodium salicylate inhibits proliferation and induces G1 cell cycle arrest in human pancreatic cancer cell lines. J. Gastrointest. Surg. 4 (2000), 24–32.
10. [10] Hardwick, J.C., van Santen, M., van den Brink, G.R., van Deventer, S.J., Peppelenbosch, M.P., DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis 25 (2004), 1293–1298.
11. 2 + uptake: inhibition by salicylate. J. Physiol. Lond. 571 (2006), 57–73.
12. [12] Valero, R.A., Senovilla, L., Nuñez, L., Villalobos, C., The role of mitochondrial potential in control of calcium signals involved in cell proliferation. Cell Calcium 44 (2008), 259–269.
13. [13] Putney, J.W., A model for receptor-regulated calcium entry. Cell Calcium 7 (1986), 1–12.
14. [14] Putney, J.W., Capacitative calcium entry revisited. Cell Calcium 11 (1990), 611–624.
15. [15] Parekh, A.B., Putney, J.W., Store-operated calcium channels. Physiol. Rev. 85 (2005), 757–810.
16. [16] Capiod, T., Shuba, Y., Skryma, R., Prevarskaya, N., Calcium signalling and cancer cell growth. Subcell. Biochem. 45 (2007), 405–427.
17. 2 + for cancer cell proliferation and survival. Nat. Rev. Cancer 8 (2008), 361–375.
18. [18] Dubois, C., Vanden Abeele, F., Lehen'kyi, V., Gkika, D., Guarmit, B., Lepage, G., Slomianny, C., Borowiec, A.S., Bidaux, G., Benahmed, M., Shuba, Y., Prevarskaya, N., Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer. Cancer Cell 26 (2014), 19–32.
19. 2 + remodeling and cancer hallmarks in colorectal carcinoma cells. J. Biol. Chem. 289 (2014), 28765–28782.
20. 2 + influx. Curr. Biol. 15 (2005), 1235–1241.
21. [21] Feske, S., Gwack, Y., Prakriya, M., Srikanth, S., Puppel, S.H., Tanasa, B., Hogan, P.G., Lewis, R.S., Daly, M., Rao, A., A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441 (2006), 179–185.
22. 2 + entry-mediated signaling is important for cancer spread. Biochim. Biophys. Acta 1863 (2016), 1427–1435.
23. [23] Fiorio Pla, A., Kondratska, K., Prevarskaya, N., STIM and ORAI proteins: crucial roles in hallmarks of cancer. Am. J. Phys. Cell Physiol. 310 (2016), C509–C519.
24. [24] Villalobos, C., Sobradillo, D., Hernández-Morales, M., Nuñez, L., Remodeling of calcium entry pathways in cancer. Adv. Exp. Med. Biol. 898 (2016), 449–466.
25. 2 + signaling. Biochim. Biophys. Acta 1863 (2016), 1364–1378.
26. [26] Baughman, J.M., Perocchi, F., Girgis, H.S., Plovanich, M., Belcher-Timme, C.A., Sancak, Y., Bao, X.R., Strittmatter, L., Goldberger, O., Bogorad, R.L., Koteliansky, V., Mootha, V.K., Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476 (2011), 341–345.
27. [27] De Stefani, D., Raffaello, A., Teardo, E., Szabò, I., Rizzuto, R., A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476 (2011), 336–340.
28. 2 + among cytosol and organella during stimulation of bovine chromaffin cells. FASEB J. 16 (2002), 343–353.
29. 2 + transients that modulate secretion. Nat. Cell Biol. 2 (2000), 57–61.
30. 2 +] domains generated by spontaneous electric activity. J. Biol. Chem. 276 (2001), 40293–40297.
31. 2 + microdomains in the control of cell survival, apoptosis and autophagy. Cell Calcium 60 (2016), 74–87.
32. [32] Hoth, M., Fanger, C.M., Lewis, R.S., Mitochondrial regulation of store-operated calcium signaling in T lymphocytes. J. Cell Biol. 137 (1997), 633–648.
33. 2 + current Icrac. EMBO J. 19 (2000), 6401–6407.
34. [34] Quintana, A., Pasche, M., Junker, C., Al-Ansary, D., Rieger, H., Kummerow, C., Nuñez, L., Villalobos, C., Meraner, P., Becherer, U., Rettig, J., Niemeyer, B.A., Hoth, M., Calcium microdomains at the immunological synapse: how ORAI channels, mitochondria and calcium pumps generate local calcium signals for efficient T-cell activation. EMBO J. 30 (2011), 3895–3912.
35. 2 +] in the endoplasmic reticulum with aequorin. Cell Calcium 32 (2002), 251–260.
36. 2 + levels. Cell 131 (2007), 1327–1339.
37. [37] Hoth, M., Niemeyer, B.A., The neglected CRAC proteins: Orai2, Orai3, and STIM2. Curr. Top. Membr. 1 (2013), 237–271.
38. 2 + entry. Curr. Top. Membr. 71 (2013), 149–179.
39. [39] Arber, N., Levin, B., Chemoprevention of colorectal neoplasia: the potential for personalized medicine. Gastroenterology 134 (2008), 1224–1237.
40. [40] Burn, J., Mathers, J.C., Bishop, D.T., Chemoprevention in Lynch syndrome. Familial Cancer 12 (2013), 707–718.
41. [41] Patrignani, P., Patrono, C., Aspirin and cancer. J. Am. Coll. Cardiol. 68 (2016), 967–976.
42. [42] Weiss, H., Amberger, A., Widschwendter, M., Margreiter, R., Ofner, D., Dietl, P., Inhibition of store-operated calcium entry contributes to the anti-proliferative effect of non-steroidal anti-inflammatory drugs in human colon cancer cells. Int. J. Cancer 92 (2001), 877–882.
43. [43] Gutknecht, J., Aspirin, acetaminophen and proton transport through phospholipid bilayers and mitochondrial membranes. Mol. Cell. Biochem. 114 (1992), 3–8.
44. 2 +-dependent inactivation of calcium release-activated calcium/Orai channels normally prevented by mitochondria. J. Biol. Chem. 286 (2011), 16186–16196.
45. 2 + remodeling during the phenotypic journey of human coronary smooth muscle cells. Cell Calcium 54 (2013), 375–385.
46. [46] Monteith, G.R., Davis, F.M., Roberts-Thomson, S.J., Calcium channels and pumps in cancer: changes and consequences. J. Biol. Chem. 287 (2012), 31666–31673.
47. 2 + transport in cancer: how it contributes to cancer hallmarks?. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci., 369, 2014, 20130097.
48. [48] Prevarskaya, N., Skryma, R., Shuba, Y., Calcium in tumor metastasis: new roles for known actors. Nat. Rev. Cancer 11 (2011), 609–618.
49. [49] Zhang, L., Zhou, W., Velculescu, V.E., Kern, S.E., Hruban, R.H., Hamilton, S.R., Vogelstein, B., Kinzler, K.W., Gene expression profiles in normal and cancer cells. Science 276 (1997), 1268–1272.
50. [50] Toyota, M., Ho, C., Ohe-Toyota, M., Baylin, S.B., Issa, J.P., Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors. Cancer Res. 5 (1999), 4535–4541.
51. [51] Yang, S., Zhang, J.J., Huang, X.Y., Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 5 (2009), 124–134.
52. [52] Chen, Y.F., Chiu, W.T., Chen, Y.T., Lin, P.Y., Huang, H.J., Chou, C.Y., Chang, H.C., Tang, M.J., Shen, M.R., Calcium store sensor stromal-interaction molecule1-dependent signaling plays an important role in cervical cancer growth, migration and angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 15225–15230.
53. [53] Li, G., Zhang, Z., Wang, R., Ma, W., Yang, Y., Wei, J., Wei, Y., Suppression of STIM1 inhibits human glioblastoma cell proliferation and induces G0/G1 phase arrest. J. Exp. Clin. Cancer Res., 32, 2013, 20.
54. [54] Motiani, R.K., Hyzinski-García, M.C., Zhang, X., Henkel, M.M., Abdullaev, I.F., Kuo, Y.H., Matrougui, K., Mongin, A.A., Trebak, M., STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion. Pflugers Arch. 465 (2013), 1249–1260.
55. [55] Faouzi, M., Hague, F., Potier, M., Ahidouch, A., Sevestre, H., Ouadid-Ahidouch, H., Down-regulation of Orai3 arrests cell-cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells. J. Cell. Physiol. 226 (2011), 542–551.
56. CRAC controls the rapid androgen response in human primary prostate epithelial cells and is altered in prostate cancer. Oncotarget 4 (2013), 2096–2107.
57. 2 + signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors. Biochim. Biophys. Acta 1835 (2013), 180–193.
58. [58] Wang, X.T., Nagaba, Y., Cross, H.S., Wrba, F., Zhang, L., Guggino, S.E., The mRNA of L-type calcium channel elevated in colon cancer: protein distribution in normal and cancerous colon. Am. J. Pathol. 157 (2000), 1549–1562.
59. [59] Wang, J.Y., Sun, J., Huang, M.Y., Wang, Y.S., Hou, M.F., Sun, Y., He, H., Krishna, N., Chiu, S.J., Lin, S., Yang, S., Chang, W.C., STIM1 overexpression promotes colorectal cancer progression, cell motility and COX-2 expression. Oncogene 34 (2015), 4358–4367.
60. [60] Aung, C.S., Ye, W., Plowman, G., Peters, A.A., Monteith, G.R., Roberts-Thomson, S.J., Plasma membrane calcium ATPase 4 and the remodeling of calcium homeostasis in human colon cancer cells. Carcinogenesis 30 (2009), 1962–1969.
61. [61] Alcarraz-Vizán, G., Sánchez-Tena, S., Moyer, M.P., Cascante, M., Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study. Biochim. Biophys. Acta 1840 (2014), 1634–1639.
62. [62] Chantôme, A., Potier-Cartereau, M., Clarysse, L., Fromont, G., Marionneau-Lambot, S., Guéguinou, M., Pagès, J.C., Collin, C., Oullier, T., Girault, A., Arbion, F., Haelters, J.P., Jaffrès, P.A., Pinault, M., Besson, P., Joulin, V., Bougnoux, P., Vandier, C., Pivotal role of the lipid Raft SK3-Orai1 complex in human cancer cell migration and bone metastases. Cancer Res. 73 (2013), 4852–4861.
63. [63] Wong, H.S., Chang, W.C., Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers. Oncotarget 6 (2015), 42169–42182.
64. [64] Guéguinou, M., Harnois, T., Crottes, D., Uguen, A., Deliot, N., Gambade, A., Chantôme, A., Haelters, J.P., Jaffrès, P.A., Jourdan, M.L., Weber, G., Soriani, O., Bougnoux, P., Mignen, O., Bourmeyster, N., Constantin, B., Lecomte, T., Vandier, C., Potier-Cartereau, M., SK3/TRPC1/Orai1 complex regulates SOCE-dependent colon cancer cell migration: a novel opportunity to modulate anti-EGFR mAb action by the alkyl-lipid Ohmline. Oncotarget 7 (2016), 36168–36184.
65. [65] Aytes, A., Molleví, D.G., Martinez-Iniesta, M., Nadal, M., Vidal, A., Morales, A., Salazar, R., Capellà, G., Villanueva, A., Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype. Mol. Carcinog. 51 (2012), 746–753.
66. [66] Ashida, S., Orloff, M.S., Bebek, G., Zhang, L., Zheng, P., Peehl, D.M., Eng, C., Integrated analysis reveals critical genomic regions in prostate tumor microenvironment associated with clinicopathologic phenotypes. Clin. Cancer Res. 18 (2012), 1578–1587.